Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Aminolevulinic acid hydrochloride
Drug ID BADD_D00111
Description A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem]
Indications and Usage Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp.
Marketing Status Prescription
ATC Code L01XD04
DrugBank ID DB00855
KEGG ID D02908
MeSH ID D000622
PubChem ID 123608
TTD Drug ID D0O4GY
NDC Product Code 71469-231; 67308-101; 70621-101; 71956-001
Synonyms Aminolevulinic Acid | Acid, Aminolevulinic | Delta-Aminolevulinic Acid | Acid, Delta-Aminolevulinic | Delta Aminolevulinic Acid | Levulan | 5-Aminolaevulinate | 5 Aminolaevulinate | 5-Aminolevulinate | 5 Aminolevulinate | Aminolevulinic Acid Hydrochloride | Acid Hydrochloride, Aminolevulinic | Hydrochloride, Aminolevulinic Acid
Chemical Information
Molecular Formula C5H10ClNO3
CAS Registry Number 5451-09-2
SMILES C(CC(=O)O)C(=O)CN.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blister23.03.01.001; 12.01.06.002--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Diplopia17.17.01.005; 06.02.06.002--Not Available
Discomfort08.01.08.003--Not Available
Dysaesthesia17.02.06.003--
Erythema23.03.06.001--Not Available
Eye discharge06.04.05.001--Not Available
Eye irritation06.04.05.003--Not Available
Hyperaesthesia17.02.06.004--Not Available
Ocular hyperaemia06.04.05.004--Not Available
Oedema08.01.07.006; 14.05.06.010--Not Available
Pain08.01.08.004--
Paraesthesia17.02.06.005--
Photophobia17.17.02.006; 06.01.01.004--
Pruritus23.03.12.001--
Rash pustular23.03.10.003; 11.01.12.002--
Scab23.03.03.004--Not Available
Skin discolouration23.03.03.005--Not Available
Skin disorder23.03.03.007--Not Available
Skin erosion23.07.03.002--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin hyperpigmentation23.05.01.003--
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009--Not Available
Swelling08.01.03.015--Not Available
Tenderness08.01.08.005--Not Available
Ulcer08.03.06.001--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vision blurred06.02.06.007; 17.17.01.010--
Wound secretion12.01.08.007; 08.01.03.035--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages